School-aged Outcomes Post Hypoxic Ischaemic Encephalopathy
SOPHIE
2 other identifiers
observational
196
1 country
1
Brief Summary
Neonatal HIE increases the risk for cognitive impairments in childhood. Neonatal MRI brain scans are a strong predictor for outcome, however a normal scan has only a 35% sensitivity and 85% specificity for a normal outcome. This may be explained by variability in the brain's development over time in response to the initial insult. This project will aim to develop a neonatal MRI machine learning algorithm that incorporates both initial injury and radiomic features associated with future brain development (based on school-age MRI) to predict school-age outcome. This will be achieved by conducting a case-control cohort study looking at School-age MRI and outcomes of children with a history of neonatal HIE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2024
CompletedFirst Submitted
Initial submission to the registry
July 9, 2026
CompletedFirst Posted
Study publicly available on registry
August 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
August 18, 2026
August 1, 2026
3.8 years
July 9, 2026
August 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Intelligence Quotient
Kaufman Brief Intelligence Test Second Edition (KBIT-2) is a brief measure of verbal and nonverbal intelligence used with individuals aged from 4 to 90 years.
Visit 1 - Approx 1.5 hours, aged 5-12 years old
Assessment of Exectuive Function
Cambridge Neuropsychological Test Automated Battery (CANTAB) will be used to assess the following domains: Visual Memory- Delayed Match to Sample (DMS) Working memory- Spatial Working Memory Task (SWM), Spatial Span Task (SSP), Digit Span Task (DGS) Attention/processing speed- Reaction Time Task (RTI), Rapid Visual Processing Task (RVP), Motor Screening Task (MOT) Inhibitory control- Stop Signal Task (SST)
Visit 1 - Approx 1.5 hours, aged 5-12 years old
Volumetric analysis of MRI brain
Total and regional brain volumetric analysis
Visit 2 - 20 minute MRI scan, approximately 2-4 months after Visit 1
Connectivity analysis of MRI brain
Analysis of brain connectivity using diffusion tensor data and fransctional anisotopy imaging.
Visit 2 - 20 minute MRI scan, approximately 2-4 months after Visit 1
MRI Machine Learning Model
Using MRIs completed at school-age and neonatal data, extract radiomic features and ragions of interest (ROIs) to develop machine learning models to predict school-aged cognitive outcome.
Visit 2 - 20 minute MRI scan, approximately 2-4 months after Visit 1
Secondary Outcomes (4)
Behavioural Profile
Visit 1 - Approx 1.5 hours, aged 5-12 years old
Incidence of additional school supports
Visit 1 - Approx 1.5 hours, aged 5-12 years old
Socioeconomic Background
Visit 1 - Approx 1.5 hours, aged 5-12 years old
Cognitively Stimulating Home Environment
Visit 1 - Approx 1.5 hours, aged 5-12 years old
Study Arms (2)
Hypoxic Ischaemic Encephalopathy (Case)
Children aged 5-12 years old with HIE meeting study inclusion criteria
Age-Matched Control
Healthy controls aged 5-12 years old, now attending mainstream school, who did not have HIE or were not admitted to the neonatal unit within 12 hours of birth.
Eligibility Criteria
Cases: Potential participants will be identified from seven previous studies conducted in Cork University Maternity Hospital (CUMH), between January 2013-December 2019. Over this period, term infants ≥36 weeks considered at significant risk of HIE were recruited prospectively to these studies as soon as possible after delivery. Clinical data, blood biomarkers, MRI and EEG recordings were collected and stored in the INFANT databank using unique study numbers. Controls: Children aged between 4-12 years of age, who are attending general paediatric outpatients' clinics at Cork University Hospital (CUH) will be selected as potential participants for the control group. Controls will be healthy children born at ≥ 36 weeks gestation now attending mainstream school who did not have a diagnosis of HIE at birth. To be eligible, they must not have been admitted to the neonatal unit in the first 12 hours after birth and have had a 5-minute Apgar score of ≥7.
You may qualify if:
- Known diagnosis of HIE of any grade and enrolled in one of seven studies carried out in CUMH and born between 01 JAN 2013 and 31 DEC 2020
- Documented parental informed consent for their study data to be used in the future for related research and for them to be contacted again.
You may not qualify if:
- Lack of parental consent for the original study and no permission to be contacted for future research.
- Death prior to study initiation
- Congenital malformation or genetic syndrome
- Controls:
- Born at ≥ 36 weeks gestation
- Attending mainstream primary school without a specific developmental diagnosis
- Diagnosis of perinatal asphyxia or HIE at birth
- Admission to the neonatal unit within 12 hours of birth
- Attending a paediatric clinic for a developmental concern
- Congenital malformation or genetic syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University College Cork
Cork, Cork, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian H Walsh, PhD
University College Cork
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Neonatologist
Study Record Dates
First Submitted
July 9, 2026
First Posted
August 18, 2026
Study Start
March 9, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
August 18, 2026
Record last verified: 2026-08